Medical Care
Global P2X7 Receptor Antagonists Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1905
- Pages: 94
- Figures: 117
- Views: 2
P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.
Market Analysis and Insights: Global P2X7 Receptor Antagonists Market
The global P2X7 Receptor Antagonists market is projected to grow from US$ 62 million in 2024 to US$ 112.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
The US & Canada market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of P2X7 Receptor Antagonists include GlaxoSmithKline, AstraZeneca, Janssen, RaQualia Pharma, Evotec, Asahi Kasei Pharma and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
P2X7 Receptor Antagonists is widely used in various fields, such as Inflammatory Diseases, Central Nervous System Diseases and Immune System Disorders,, etc. Inflammatory Diseases provides greatest supports to the P2X7 Receptor Antagonists industry development. In 2023, global % revenue of P2X7 Receptor Antagonists went into Inflammatory Diseases filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for P2X7 Receptor Antagonists market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of P2X7 Receptor Antagonists, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for P2X7 Receptor Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the P2X7 Receptor Antagonists revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global P2X7 Receptor Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for P2X7 Receptor Antagonists revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer
Segment by Type
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Segment by Application
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of P2X7 Receptor Antagonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of P2X7 Receptor Antagonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, P2X7 Receptor Antagonists revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global P2X7 Receptor Antagonists Market
The global P2X7 Receptor Antagonists market is projected to grow from US$ 62 million in 2024 to US$ 112.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
The US & Canada market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for P2X7 Receptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of P2X7 Receptor Antagonists include GlaxoSmithKline, AstraZeneca, Janssen, RaQualia Pharma, Evotec, Asahi Kasei Pharma and Pfizer, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
P2X7 Receptor Antagonists is widely used in various fields, such as Inflammatory Diseases, Central Nervous System Diseases and Immune System Disorders,, etc. Inflammatory Diseases provides greatest supports to the P2X7 Receptor Antagonists industry development. In 2023, global % revenue of P2X7 Receptor Antagonists went into Inflammatory Diseases filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for P2X7 Receptor Antagonists market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of P2X7 Receptor Antagonists, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for P2X7 Receptor Antagonists, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the P2X7 Receptor Antagonists revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global P2X7 Receptor Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for P2X7 Receptor Antagonists revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer
Segment by Type
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Segment by Application
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of P2X7 Receptor Antagonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of P2X7 Receptor Antagonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, P2X7 Receptor Antagonists revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 GSK1482160
1.2.3 AZD9056
1.2.4 EVT 401
1.2.5 JNJ 55308942 & JNJ 54175446
1.2.6 AKP-23494954/RQ-00466479
1.2.7 Others
1.3 Market by Application
1.3.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Inflammatory Diseases
1.3.3 Central Nervous System Diseases
1.3.4 Immune System Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global P2X7 Receptor Antagonists Market Perspective (2019-2030)
2.2 Global P2X7 Receptor Antagonists Growth Trends by Region
2.2.1 P2X7 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 P2X7 Receptor Antagonists Historic Market Size by Region (2019-2024)
2.2.3 P2X7 Receptor Antagonists Forecasted Market Size by Region (2025-2030)
2.3 P2X7 Receptor Antagonists Market Dynamics
2.3.1 P2X7 Receptor Antagonists Industry Trends
2.3.2 P2X7 Receptor Antagonists Market Drivers
2.3.3 P2X7 Receptor Antagonists Market Challenges
2.3.4 P2X7 Receptor Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue P2X7 Receptor Antagonists by Players
3.1.1 Global P2X7 Receptor Antagonists Revenue by Players (2019-2024)
3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by Players (2019-2024)
3.2 Global P2X7 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of P2X7 Receptor Antagonists, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global P2X7 Receptor Antagonists Market Concentration Ratio
3.4.1 Global P2X7 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by P2X7 Receptor Antagonists Revenue in 2023
3.5 Global Key Players of P2X7 Receptor Antagonists Head office and Area Served
3.6 Global Key Players of P2X7 Receptor Antagonists, Product and Application
3.7 Global Key Players of P2X7 Receptor Antagonists, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 P2X7 Receptor Antagonists Breakdown Data by Type
4.1 Global P2X7 Receptor Antagonists Historic Market Size by Type (2019-2024)
4.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2025-2030)
5 P2X7 Receptor Antagonists Breakdown Data by Application
5.1 Global P2X7 Receptor Antagonists Historic Market Size by Application (2019-2024)
5.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America P2X7 Receptor Antagonists Market Size (2019-2030)
6.2 North America P2X7 Receptor Antagonists Market Size by Type
6.2.1 North America P2X7 Receptor Antagonists Market Size by Type (2019-2024)
6.2.2 North America P2X7 Receptor Antagonists Market Size by Type (2025-2030)
6.2.3 North America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
6.3 North America P2X7 Receptor Antagonists Market Size by Application
6.3.1 North America P2X7 Receptor Antagonists Market Size by Application (2019-2024)
6.3.2 North America P2X7 Receptor Antagonists Market Size by Application (2025-2030)
6.3.3 North America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
6.4 North America P2X7 Receptor Antagonists Market Size by Country
6.4.1 North America P2X7 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America P2X7 Receptor Antagonists Market Size by Country (2019-2024)
6.4.3 North America P2X7 Receptor Antagonists Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe P2X7 Receptor Antagonists Market Size (2019-2030)
7.2 Europe P2X7 Receptor Antagonists Market Size by Type
7.2.1 Europe P2X7 Receptor Antagonists Market Size by Type (2019-2024)
7.2.2 Europe P2X7 Receptor Antagonists Market Size by Type (2025-2030)
7.2.3 Europe P2X7 Receptor Antagonists Market Share by Type (2019-2030)
7.3 Europe P2X7 Receptor Antagonists Market Size by Application
7.3.1 Europe P2X7 Receptor Antagonists Market Size by Application (2019-2024)
7.3.2 Europe P2X7 Receptor Antagonists Market Size by Application (2025-2030)
7.3.3 Europe P2X7 Receptor Antagonists Market Share by Application (2019-2030)
7.4 Europe P2X7 Receptor Antagonists Market Size by Country
7.4.1 Europe P2X7 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024)
7.4.3 Europe P2X7 Receptor Antagonists Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China P2X7 Receptor Antagonists Market Size (2019-2030)
8.2 China P2X7 Receptor Antagonists Market Size by Type
8.2.1 China P2X7 Receptor Antagonists Market Size by Type (2019-2024)
8.2.2 China P2X7 Receptor Antagonists Market Size by Type (2025-2030)
8.2.3 China P2X7 Receptor Antagonists Market Share by Type (2019-2030)
8.3 China P2X7 Receptor Antagonists Market Size by Application
8.3.1 China P2X7 Receptor Antagonists Market Size by Application (2019-2024)
8.3.2 China P2X7 Receptor Antagonists Market Size by Application (2025-2030)
8.3.3 China P2X7 Receptor Antagonists Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia P2X7 Receptor Antagonists Market Size (2019-2030)
9.2 Asia P2X7 Receptor Antagonists Market Size by Type
9.2.1 Asia P2X7 Receptor Antagonists Market Size by Type (2019-2024)
9.2.2 Asia P2X7 Receptor Antagonists Market Size by Type (2025-2030)
9.2.3 Asia P2X7 Receptor Antagonists Market Share by Type (2019-2030)
9.3 Asia P2X7 Receptor Antagonists Market Size by Application
9.3.1 Asia P2X7 Receptor Antagonists Market Size by Application (2019-2024)
9.3.2 Asia P2X7 Receptor Antagonists Market Size by Application (2025-2030)
9.3.3 Asia P2X7 Receptor Antagonists Market Share by Application (2019-2030)
9.4 Asia P2X7 Receptor Antagonists Market Size by Region
9.4.1 Asia P2X7 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia P2X7 Receptor Antagonists Market Size by Region (2019-2024)
9.4.3 Asia P2X7 Receptor Antagonists Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type
10.2.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application
10.3.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country
10.4.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Introduction
11.1.4 GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca P2X7 Receptor Antagonists Introduction
11.2.4 AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Janssen
11.3.1 Janssen Company Details
11.3.2 Janssen Business Overview
11.3.3 Janssen P2X7 Receptor Antagonists Introduction
11.3.4 Janssen Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.3.5 Janssen Recent Developments
11.4 RaQualia Pharma
11.4.1 RaQualia Pharma Company Details
11.4.2 RaQualia Pharma Business Overview
11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Introduction
11.4.4 RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.4.5 RaQualia Pharma Recent Developments
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec P2X7 Receptor Antagonists Introduction
11.5.4 Evotec Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.5.5 Evotec Recent Developments
11.6 Asahi Kasei Pharma
11.6.1 Asahi Kasei Pharma Company Details
11.6.2 Asahi Kasei Pharma Business Overview
11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Introduction
11.6.4 Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.6.5 Asahi Kasei Pharma Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer P2X7 Receptor Antagonists Introduction
11.7.4 Pfizer Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.7.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 GSK1482160
1.2.3 AZD9056
1.2.4 EVT 401
1.2.5 JNJ 55308942 & JNJ 54175446
1.2.6 AKP-23494954/RQ-00466479
1.2.7 Others
1.3 Market by Application
1.3.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Inflammatory Diseases
1.3.3 Central Nervous System Diseases
1.3.4 Immune System Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global P2X7 Receptor Antagonists Market Perspective (2019-2030)
2.2 Global P2X7 Receptor Antagonists Growth Trends by Region
2.2.1 P2X7 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 P2X7 Receptor Antagonists Historic Market Size by Region (2019-2024)
2.2.3 P2X7 Receptor Antagonists Forecasted Market Size by Region (2025-2030)
2.3 P2X7 Receptor Antagonists Market Dynamics
2.3.1 P2X7 Receptor Antagonists Industry Trends
2.3.2 P2X7 Receptor Antagonists Market Drivers
2.3.3 P2X7 Receptor Antagonists Market Challenges
2.3.4 P2X7 Receptor Antagonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue P2X7 Receptor Antagonists by Players
3.1.1 Global P2X7 Receptor Antagonists Revenue by Players (2019-2024)
3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by Players (2019-2024)
3.2 Global P2X7 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of P2X7 Receptor Antagonists, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global P2X7 Receptor Antagonists Market Concentration Ratio
3.4.1 Global P2X7 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by P2X7 Receptor Antagonists Revenue in 2023
3.5 Global Key Players of P2X7 Receptor Antagonists Head office and Area Served
3.6 Global Key Players of P2X7 Receptor Antagonists, Product and Application
3.7 Global Key Players of P2X7 Receptor Antagonists, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 P2X7 Receptor Antagonists Breakdown Data by Type
4.1 Global P2X7 Receptor Antagonists Historic Market Size by Type (2019-2024)
4.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2025-2030)
5 P2X7 Receptor Antagonists Breakdown Data by Application
5.1 Global P2X7 Receptor Antagonists Historic Market Size by Application (2019-2024)
5.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America P2X7 Receptor Antagonists Market Size (2019-2030)
6.2 North America P2X7 Receptor Antagonists Market Size by Type
6.2.1 North America P2X7 Receptor Antagonists Market Size by Type (2019-2024)
6.2.2 North America P2X7 Receptor Antagonists Market Size by Type (2025-2030)
6.2.3 North America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
6.3 North America P2X7 Receptor Antagonists Market Size by Application
6.3.1 North America P2X7 Receptor Antagonists Market Size by Application (2019-2024)
6.3.2 North America P2X7 Receptor Antagonists Market Size by Application (2025-2030)
6.3.3 North America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
6.4 North America P2X7 Receptor Antagonists Market Size by Country
6.4.1 North America P2X7 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America P2X7 Receptor Antagonists Market Size by Country (2019-2024)
6.4.3 North America P2X7 Receptor Antagonists Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe P2X7 Receptor Antagonists Market Size (2019-2030)
7.2 Europe P2X7 Receptor Antagonists Market Size by Type
7.2.1 Europe P2X7 Receptor Antagonists Market Size by Type (2019-2024)
7.2.2 Europe P2X7 Receptor Antagonists Market Size by Type (2025-2030)
7.2.3 Europe P2X7 Receptor Antagonists Market Share by Type (2019-2030)
7.3 Europe P2X7 Receptor Antagonists Market Size by Application
7.3.1 Europe P2X7 Receptor Antagonists Market Size by Application (2019-2024)
7.3.2 Europe P2X7 Receptor Antagonists Market Size by Application (2025-2030)
7.3.3 Europe P2X7 Receptor Antagonists Market Share by Application (2019-2030)
7.4 Europe P2X7 Receptor Antagonists Market Size by Country
7.4.1 Europe P2X7 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024)
7.4.3 Europe P2X7 Receptor Antagonists Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China P2X7 Receptor Antagonists Market Size (2019-2030)
8.2 China P2X7 Receptor Antagonists Market Size by Type
8.2.1 China P2X7 Receptor Antagonists Market Size by Type (2019-2024)
8.2.2 China P2X7 Receptor Antagonists Market Size by Type (2025-2030)
8.2.3 China P2X7 Receptor Antagonists Market Share by Type (2019-2030)
8.3 China P2X7 Receptor Antagonists Market Size by Application
8.3.1 China P2X7 Receptor Antagonists Market Size by Application (2019-2024)
8.3.2 China P2X7 Receptor Antagonists Market Size by Application (2025-2030)
8.3.3 China P2X7 Receptor Antagonists Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia P2X7 Receptor Antagonists Market Size (2019-2030)
9.2 Asia P2X7 Receptor Antagonists Market Size by Type
9.2.1 Asia P2X7 Receptor Antagonists Market Size by Type (2019-2024)
9.2.2 Asia P2X7 Receptor Antagonists Market Size by Type (2025-2030)
9.2.3 Asia P2X7 Receptor Antagonists Market Share by Type (2019-2030)
9.3 Asia P2X7 Receptor Antagonists Market Size by Application
9.3.1 Asia P2X7 Receptor Antagonists Market Size by Application (2019-2024)
9.3.2 Asia P2X7 Receptor Antagonists Market Size by Application (2025-2030)
9.3.3 Asia P2X7 Receptor Antagonists Market Share by Application (2019-2030)
9.4 Asia P2X7 Receptor Antagonists Market Size by Region
9.4.1 Asia P2X7 Receptor Antagonists Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia P2X7 Receptor Antagonists Market Size by Region (2019-2024)
9.4.3 Asia P2X7 Receptor Antagonists Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type
10.2.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application
10.3.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country
10.4.1 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Introduction
11.1.4 GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca P2X7 Receptor Antagonists Introduction
11.2.4 AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Janssen
11.3.1 Janssen Company Details
11.3.2 Janssen Business Overview
11.3.3 Janssen P2X7 Receptor Antagonists Introduction
11.3.4 Janssen Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.3.5 Janssen Recent Developments
11.4 RaQualia Pharma
11.4.1 RaQualia Pharma Company Details
11.4.2 RaQualia Pharma Business Overview
11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Introduction
11.4.4 RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.4.5 RaQualia Pharma Recent Developments
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec P2X7 Receptor Antagonists Introduction
11.5.4 Evotec Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.5.5 Evotec Recent Developments
11.6 Asahi Kasei Pharma
11.6.1 Asahi Kasei Pharma Company Details
11.6.2 Asahi Kasei Pharma Business Overview
11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Introduction
11.6.4 Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.6.5 Asahi Kasei Pharma Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer P2X7 Receptor Antagonists Introduction
11.7.4 Pfizer Revenue in P2X7 Receptor Antagonists Business (2019-2024)
11.7.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of GSK1482160
Table 3. Key Players of AZD9056
Table 4. Key Players of EVT 401
Table 5. Key Players of JNJ 55308942 & JNJ 54175446
Table 6. Key Players of AKP-23494954/RQ-00466479
Table 7. Key Players of Others
Table 8. Global P2X7 Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 9. Global P2X7 Receptor Antagonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global P2X7 Receptor Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global P2X7 Receptor Antagonists Market Share by Region (2019-2024)
Table 12. Global P2X7 Receptor Antagonists Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global P2X7 Receptor Antagonists Market Share by Region (2025-2030)
Table 14. P2X7 Receptor Antagonists Market Trends
Table 15. P2X7 Receptor Antagonists Market Drivers
Table 16. P2X7 Receptor Antagonists Market Challenges
Table 17. P2X7 Receptor Antagonists Market Restraints
Table 18. Global P2X7 Receptor Antagonists Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global P2X7 Receptor Antagonists Revenue Share by Players (2019-2024)
Table 20. Global Top P2X7 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2023)
Table 21. Global P2X7 Receptor Antagonists Industry Ranking 2022 VS 2023 VS 2024
Table 22. Global 5 Largest Players Market Share by P2X7 Receptor Antagonists Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of P2X7 Receptor Antagonists, Headquarters and Area Served
Table 24. Global Key Players of P2X7 Receptor Antagonists, Product and Application
Table 25. Global Key Players of P2X7 Receptor Antagonists, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 29. Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 31. Global P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global P2X7 Receptor Antagonists Revenue Share by Application (2019-2024)
Table 33. Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global P2X7 Receptor Antagonists Revenue Share by Application (2025-2030)
Table 35. North America P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 36. North America P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 37. North America P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 38. North America P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 39. North America P2X7 Receptor Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. North America P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 41. North America P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 42. Europe P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 43. Europe P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 44. Europe P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 45. Europe P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 46. Europe P2X7 Receptor Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 48. Europe P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 49. China P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 50. China P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 51. China P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 52. China P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 54. Asia P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 55. Asia P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 56. Asia P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 57. Asia P2X7 Receptor Antagonists Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 58. Asia P2X7 Receptor Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 59. Asia P2X7 Receptor Antagonists Market Size by Region (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 64. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 65. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline P2X7 Receptor Antagonists Product
Table 70. GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Developments
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca P2X7 Receptor Antagonists Product
Table 75. AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Developments
Table 77. Janssen Company Details
Table 78. Janssen Business Overview
Table 79. Janssen P2X7 Receptor Antagonists Product
Table 80. Janssen Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 81. Janssen Recent Developments
Table 82. RaQualia Pharma Company Details
Table 83. RaQualia Pharma Business Overview
Table 84. RaQualia Pharma P2X7 Receptor Antagonists Product
Table 85. RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 86. RaQualia Pharma Recent Developments
Table 87. Evotec Company Details
Table 88. Evotec Business Overview
Table 89. Evotec P2X7 Receptor Antagonists Product
Table 90. Evotec Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 91. Evotec Recent Developments
Table 92. Asahi Kasei Pharma Company Details
Table 93. Asahi Kasei Pharma Business Overview
Table 94. Asahi Kasei Pharma P2X7 Receptor Antagonists Product
Table 95. Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 96. Asahi Kasei Pharma Recent Developments
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer P2X7 Receptor Antagonists Product
Table 100. Pfizer Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 101. Pfizer Recent Developments
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global P2X7 Receptor Antagonists Market Share by Type: 2023 VS 2030
Figure 3. GSK1482160 Features
Figure 4. AZD9056 Features
Figure 5. EVT 401 Features
Figure 6. JNJ 55308942 & JNJ 54175446 Features
Figure 7. AKP-23494954/RQ-00466479 Features
Figure 8. Others Features
Figure 9. Global P2X7 Receptor Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global P2X7 Receptor Antagonists Market Share by Application: 2023 VS 2030
Figure 11. Inflammatory Diseases Case Studies
Figure 12. Central Nervous System Diseases Case Studies
Figure 13. Immune System Disorders Case Studies
Figure 14. P2X7 Receptor Antagonists Report Years Considered
Figure 15. Global P2X7 Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global P2X7 Receptor Antagonists Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global P2X7 Receptor Antagonists Market Share by Region: 2023 VS 2030
Figure 18. Global P2X7 Receptor Antagonists Market Share by Players in 2023
Figure 19. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by P2X7 Receptor Antagonists Revenue in 2023
Figure 21. North America P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 23. North America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 24. North America P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 25. United States P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 28. Europe P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 29. Europe P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 30. Europe P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 31. Germany P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. China P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 38. China P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 39. China P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 40. Asia P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 41. Asia P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 42. Asia P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 43. Asia P2X7 Receptor Antagonists Market Share by Region (2019-2030)
Figure 44. Japan P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. South Korea P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Taiwan P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Southeast Asia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. India P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Australia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 52. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 53. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 54. Brazil P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Mexico P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Turkey P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Israel P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. GCC Countries P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 61. AstraZeneca Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 62. Janssen Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 63. RaQualia Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 64. Evotec Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 65. Asahi Kasei Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 66. Pfizer Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of GSK1482160
Table 3. Key Players of AZD9056
Table 4. Key Players of EVT 401
Table 5. Key Players of JNJ 55308942 & JNJ 54175446
Table 6. Key Players of AKP-23494954/RQ-00466479
Table 7. Key Players of Others
Table 8. Global P2X7 Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 9. Global P2X7 Receptor Antagonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global P2X7 Receptor Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global P2X7 Receptor Antagonists Market Share by Region (2019-2024)
Table 12. Global P2X7 Receptor Antagonists Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global P2X7 Receptor Antagonists Market Share by Region (2025-2030)
Table 14. P2X7 Receptor Antagonists Market Trends
Table 15. P2X7 Receptor Antagonists Market Drivers
Table 16. P2X7 Receptor Antagonists Market Challenges
Table 17. P2X7 Receptor Antagonists Market Restraints
Table 18. Global P2X7 Receptor Antagonists Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global P2X7 Receptor Antagonists Revenue Share by Players (2019-2024)
Table 20. Global Top P2X7 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2023)
Table 21. Global P2X7 Receptor Antagonists Industry Ranking 2022 VS 2023 VS 2024
Table 22. Global 5 Largest Players Market Share by P2X7 Receptor Antagonists Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of P2X7 Receptor Antagonists, Headquarters and Area Served
Table 24. Global Key Players of P2X7 Receptor Antagonists, Product and Application
Table 25. Global Key Players of P2X7 Receptor Antagonists, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2019-2024)
Table 29. Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2025-2030)
Table 31. Global P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global P2X7 Receptor Antagonists Revenue Share by Application (2019-2024)
Table 33. Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global P2X7 Receptor Antagonists Revenue Share by Application (2025-2030)
Table 35. North America P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 36. North America P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 37. North America P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 38. North America P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 39. North America P2X7 Receptor Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. North America P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 41. North America P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 42. Europe P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 43. Europe P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 44. Europe P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 45. Europe P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 46. Europe P2X7 Receptor Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 48. Europe P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 49. China P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 50. China P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 51. China P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 52. China P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 54. Asia P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 55. Asia P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 56. Asia P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 57. Asia P2X7 Receptor Antagonists Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 58. Asia P2X7 Receptor Antagonists Market Size by Region (2019-2024) & (US$ Million)
Table 59. Asia P2X7 Receptor Antagonists Market Size by Region (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Type (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Application (2025-2030) & (US$ Million)
Table 64. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 65. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2019-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size by Country (2025-2030) & (US$ Million)
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline P2X7 Receptor Antagonists Product
Table 70. GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Developments
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca P2X7 Receptor Antagonists Product
Table 75. AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Developments
Table 77. Janssen Company Details
Table 78. Janssen Business Overview
Table 79. Janssen P2X7 Receptor Antagonists Product
Table 80. Janssen Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 81. Janssen Recent Developments
Table 82. RaQualia Pharma Company Details
Table 83. RaQualia Pharma Business Overview
Table 84. RaQualia Pharma P2X7 Receptor Antagonists Product
Table 85. RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 86. RaQualia Pharma Recent Developments
Table 87. Evotec Company Details
Table 88. Evotec Business Overview
Table 89. Evotec P2X7 Receptor Antagonists Product
Table 90. Evotec Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 91. Evotec Recent Developments
Table 92. Asahi Kasei Pharma Company Details
Table 93. Asahi Kasei Pharma Business Overview
Table 94. Asahi Kasei Pharma P2X7 Receptor Antagonists Product
Table 95. Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 96. Asahi Kasei Pharma Recent Developments
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer P2X7 Receptor Antagonists Product
Table 100. Pfizer Revenue in P2X7 Receptor Antagonists Business (2019-2024) & (US$ Million)
Table 101. Pfizer Recent Developments
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global P2X7 Receptor Antagonists Market Share by Type: 2023 VS 2030
Figure 3. GSK1482160 Features
Figure 4. AZD9056 Features
Figure 5. EVT 401 Features
Figure 6. JNJ 55308942 & JNJ 54175446 Features
Figure 7. AKP-23494954/RQ-00466479 Features
Figure 8. Others Features
Figure 9. Global P2X7 Receptor Antagonists Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global P2X7 Receptor Antagonists Market Share by Application: 2023 VS 2030
Figure 11. Inflammatory Diseases Case Studies
Figure 12. Central Nervous System Diseases Case Studies
Figure 13. Immune System Disorders Case Studies
Figure 14. P2X7 Receptor Antagonists Report Years Considered
Figure 15. Global P2X7 Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global P2X7 Receptor Antagonists Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global P2X7 Receptor Antagonists Market Share by Region: 2023 VS 2030
Figure 18. Global P2X7 Receptor Antagonists Market Share by Players in 2023
Figure 19. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in P2X7 Receptor Antagonists as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by P2X7 Receptor Antagonists Revenue in 2023
Figure 21. North America P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 23. North America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 24. North America P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 25. United States P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 28. Europe P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 29. Europe P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 30. Europe P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 31. Germany P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. China P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 38. China P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 39. China P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 40. Asia P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 41. Asia P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 42. Asia P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 43. Asia P2X7 Receptor Antagonists Market Share by Region (2019-2030)
Figure 44. Japan P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. South Korea P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Taiwan P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Southeast Asia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. India P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Australia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Size YoY (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Type (2019-2030)
Figure 52. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Application (2019-2030)
Figure 53. Middle East, Africa, and Latin America P2X7 Receptor Antagonists Market Share by Country (2019-2030)
Figure 54. Brazil P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Mexico P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Turkey P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Israel P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. GCC Countries P2X7 Receptor Antagonists Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 61. AstraZeneca Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 62. Janssen Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 63. RaQualia Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 64. Evotec Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 65. Asahi Kasei Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 66. Pfizer Revenue Growth Rate in P2X7 Receptor Antagonists Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232